Insulin

Tresiba 200 units/mL (U-200) single-patient-use FlexTouch Pen Images

Generic Name: insulin degludec

This medication has been identified as Tresiba 200 units/mL (U-200) single-patient-use FlexTouch Pen. It is supplied by Novo Nordisk.

Tresiba is used in the treatment of Diabetes, Type 2; Diabetes, Type 1; Diabetes Mellitus and belongs to the drug class insulin. Risk cannot be ruled out during pregnancy. Tresiba 200 units/mL (U-200) single-patient-use FlexTouch Pen is not a controlled substance under the Controlled Substances Act (CSA).

Images

Tresiba (Insulin degludec [ in-su-lin-de-gloo-dek ])-medicine-200 units/mL (U-200) single-patient-use FlexTouch Pen

Tresiba
Generic Name: insulin degludec [ in-su-lin-de-gloo-dek ]
Imprint: medicine
Strength: 200 units/mL (U-200) single-patient-use FlexTouch Pen
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Insulin
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00169-2550
Inactive Ingredients:
Latest News
Related Drugs